Diagnostic Genetic Alterations Predict Subtype-Specific Relapse in Childhood B-Cell Leukemia
Genetic changes present at diagnosis can predict subtype-specific relapse risk and differentiate second primary cancers in pediatric B-cell leukemia.
Genetic changes present at diagnosis can predict subtype-specific relapse risk and differentiate second primary cancers in pediatric B-cell leukemia.
St. Jude scientists showed that METTL13-driven methylation of the translation factor eEF1A selectively speeds decoding of codons enriched in oncogenes ...
St. Jude ranked third among U.S. pediatric cancer hospitals in an annual assessment combining clinical data and a survey of ...
St. Jude scientists found that deleting the gene ZMYND8 relieves CD8-positive T-cell exhaustion and synergizes with immunotherapy to improve anti-tumor ...
St. Jude scientists and collaborators built a comprehensive single-cell dataset and patient-derived models to identify a malignant mesenchymal cell population ...
A six-month competency-based program aligned with WHO nurse educator standards significantly improved the knowledge, teaching skills, and project implementation of ...
St. Jude Children’s Research Hospital has once again solidified its position among the elite institutions dedicated to pediatric oncology by ...
St. Jude Children’s Research Hospital has recently made significant strides by appointing Elizabeth M.C. Hillman, PhD, as the founding chair ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.